Public Funds Majority Of Medicines R&D, Must Hold Drug Companies Accountable
Thomson Reuters Foundation: Equality, Big Pharma and lifesaving medicine
John Butler, a consultant and global public health expert, and Brian Wahl, a doctoral student studying epidemiology and disease control at Johns Hopkins Bloomberg School of Public Health
“…Governments and civil society must again unite behind the simple idea that everyone has the right to health. That is, medicines must be affordable and accessible for all. With money for research and development coming largely from public sources, we must all hold pharmaceutical companies accountable and demand they serve people first…” (2/4).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.